Bio Pharma Market in India 2017
The report is sent in 0-2 business days after order is placed.
Netscribes' latest market research report titled Bio Pharma Market in India 2017 states that while historically the biopharmaceuticals market in the country grew at a CAGR of 15.7%, it is expected to grow at a CAGR of 13.6% between 2016 and 2022. With a large portion of the population falling in the senior citizen category, the need for various healthcare services and pharmaceutical products, including biopharmaceuticals is expected to rise in the country. Moreover, with increased life expectancy, this segment of the population is expected to grow further in the coming years. The increased disposable income of Indians is also allowing them to spend more on medicines and follow medication more diligently. Also, growing health awareness among individuals is resulting in early detection of various medical conditions, and leading to individuals being subject to various medications much earlier than before.
However, the lack of regulatory clarity acts as a major challenge for the industry. The regulation of biopharmaceuticals is inefficient and complex due to the involvement of multiple agencies and committees in the review and approval process. Competition from other Asian countries also acts as a challenge for the Indian bio pharma market. Despite the competition from other countries, India's biotechnology sector has attracted major investments from several global companies due to its strong generic biotechnology potential. While Indian Immunologicals Ltd. set up vaccine manufacturing facilities in Pondicherry and Hyderabad by investing INR 3 bn and INR 2.5 bn respectively, Shantha Biotechnics Pvt. Ltd. built an insulin product manufacturing facility entailing an investment of INR 4.6 bn. The country is being recognized globally as a preferred outsourcing destination for contract research and manufacturing services. This will further aid in the development of the country’s bio pharma sector. Biocon Ltd., Dr. Reddy’s Laboratories Ltd, Serum Institute of India Pvt. Ltd., Lupin Ltd. and Intas Pharmaceuticals Ltd. are some of the major companies operating in this market.
COVERAGE:
Netscribes' latest market research report titled Bio Pharma Market in India 2017 states that while historically the biopharmaceuticals market in the country grew at a CAGR of 15.7%, it is expected to grow at a CAGR of 13.6% between 2016 and 2022. With a large portion of the population falling in the senior citizen category, the need for various healthcare services and pharmaceutical products, including biopharmaceuticals is expected to rise in the country. Moreover, with increased life expectancy, this segment of the population is expected to grow further in the coming years. The increased disposable income of Indians is also allowing them to spend more on medicines and follow medication more diligently. Also, growing health awareness among individuals is resulting in early detection of various medical conditions, and leading to individuals being subject to various medications much earlier than before.
However, the lack of regulatory clarity acts as a major challenge for the industry. The regulation of biopharmaceuticals is inefficient and complex due to the involvement of multiple agencies and committees in the review and approval process. Competition from other Asian countries also acts as a challenge for the Indian bio pharma market. Despite the competition from other countries, India's biotechnology sector has attracted major investments from several global companies due to its strong generic biotechnology potential. While Indian Immunologicals Ltd. set up vaccine manufacturing facilities in Pondicherry and Hyderabad by investing INR 3 bn and INR 2.5 bn respectively, Shantha Biotechnics Pvt. Ltd. built an insulin product manufacturing facility entailing an investment of INR 4.6 bn. The country is being recognized globally as a preferred outsourcing destination for contract research and manufacturing services. This will further aid in the development of the country’s bio pharma sector. Biocon Ltd., Dr. Reddy’s Laboratories Ltd, Serum Institute of India Pvt. Ltd., Lupin Ltd. and Intas Pharmaceuticals Ltd. are some of the major companies operating in this market.
COVERAGE:
- Overview of the bio pharma market in India, and historical and forecasted market size data over 2010 to 2022
- Trade analysis of bio pharma products in India
- Qualitative analysis of the major drivers and challenges affecting the market
- Analysis of the competitive landscape and profiles of major players operating in the market
- Key recent developments in the Indian bio pharma sector
- Get a broad understanding of the bio pharma sector in India, the dynamics of the market and the current state of the sector
- Strategize marketing, market-entry, market expansion and other business plans by understanding the factors driving the growth of the market
- Be informed regarding the key developments in the Indian bio pharma sector
- Understand major competitors’ business and market dynamics, and respond accordingly
Slide 1: Executive Summary
SOCIOECONOMIC INDICATORS
Slide 2: Total Population (2010-2011 – 2019-2020), Population Density (2010-2011 – 2019-2020)
Slide 3: Sex Ratio (2005, 2010, 2015, 2020), Population by Age Group (2005, 2010, 2015, 2020), Urbanization Trend (2010-2011 – 2019-2020)
Slide 4: Total Fertility Rate (2005-2010, 2010-2015, 2015-2020), Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020), Total Number of Births (2005-2010, 2010-2015, 2015-2020), Total Number of Death (2005-2010, 2010-2015, 2015-2020)
Slide 5: Total Literacy Rate (2001, 2011), Rural Literacy (2001, 2011), Urban Literacy (2001, 2011)
Slide 6: GDP at Market Prices (2010-2014), FDI (2010-2014), Inflation Rate (2010-2014), Unemployment Rate (2010-2014)
Slide 7: Access to Safe Drinking Water (2001, 2011), Exchange Rate (2010-2015)
MARKET OVERVIEW
Slide 8: Market Definition & Structure
Slide 9: Biopharmaceuticals Market in India – Market Size & Growth (2010 –2022)
Slide 10: Biopharmaceuticals Market in India – Market Overview
Slide 11: Porter’s Five Forces Analysis
TRADE ANALYSIS
Slide 12: Export of Vaccines for Human Medicine – Size (Value-Wise; FY 2013 – FY 2017 and Volume-Wise; FY 2013 – FY 2017)
Slide 13: Export of Vaccines for Human Medicine – Country-Wise Segmentation (Value-Wise; FY 2015 and FY 2016; and Volume-Wise; FY 2015 and FY 2016)
Slide 14: Import of Vaccines for Human Medicine – Size (Value-Wise; FY 2013 – FY 2017 and Volume-Wise; FY 2013 – FY 2017)
Slide 15: Import of Vaccines for Human Medicine – Country-Wise Segmentation (Value-Wise; FY 2015 and FY 2016; and Volume-Wise; FY 2015 and FY 2016)
MARKET INFLUENCERS
Slide 16-17: Market Drivers
Slide 18: Market Challenges
MARKET TRENDS
Slide 19: Key Trends
COMPETITIVE LANDSCAPE
Slide 20: List of Major Players
Slide 21-50: Profiles of Major Players
RECENT DEVELOPMENTS
Slide 51-52: Recent Developments
APPENDIX
Slide 53: Research Methodology
SOCIOECONOMIC INDICATORS
Slide 2: Total Population (2010-2011 – 2019-2020), Population Density (2010-2011 – 2019-2020)
Slide 3: Sex Ratio (2005, 2010, 2015, 2020), Population by Age Group (2005, 2010, 2015, 2020), Urbanization Trend (2010-2011 – 2019-2020)
Slide 4: Total Fertility Rate (2005-2010, 2010-2015, 2015-2020), Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020), Total Number of Births (2005-2010, 2010-2015, 2015-2020), Total Number of Death (2005-2010, 2010-2015, 2015-2020)
Slide 5: Total Literacy Rate (2001, 2011), Rural Literacy (2001, 2011), Urban Literacy (2001, 2011)
Slide 6: GDP at Market Prices (2010-2014), FDI (2010-2014), Inflation Rate (2010-2014), Unemployment Rate (2010-2014)
Slide 7: Access to Safe Drinking Water (2001, 2011), Exchange Rate (2010-2015)
MARKET OVERVIEW
Slide 8: Market Definition & Structure
Slide 9: Biopharmaceuticals Market in India – Market Size & Growth (2010 –2022)
Slide 10: Biopharmaceuticals Market in India – Market Overview
Slide 11: Porter’s Five Forces Analysis
TRADE ANALYSIS
Slide 12: Export of Vaccines for Human Medicine – Size (Value-Wise; FY 2013 – FY 2017 and Volume-Wise; FY 2013 – FY 2017)
Slide 13: Export of Vaccines for Human Medicine – Country-Wise Segmentation (Value-Wise; FY 2015 and FY 2016; and Volume-Wise; FY 2015 and FY 2016)
Slide 14: Import of Vaccines for Human Medicine – Size (Value-Wise; FY 2013 – FY 2017 and Volume-Wise; FY 2013 – FY 2017)
Slide 15: Import of Vaccines for Human Medicine – Country-Wise Segmentation (Value-Wise; FY 2015 and FY 2016; and Volume-Wise; FY 2015 and FY 2016)
MARKET INFLUENCERS
Slide 16-17: Market Drivers
Slide 18: Market Challenges
MARKET TRENDS
Slide 19: Key Trends
COMPETITIVE LANDSCAPE
Slide 20: List of Major Players
Slide 21-50: Profiles of Major Players
RECENT DEVELOPMENTS
Slide 51-52: Recent Developments
APPENDIX
Slide 53: Research Methodology
